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Most systematic reviews rely substantially on the assessment of the methodological quality of the
individual trials. The aim of this study was to obtain consensus among experts about a set of generic core items for
quality assessment of randomized clinical trials (RCTs). The invited participants were experts in the field of
quality assessment of RCTs. The initial item pool contained all items from existing criteria lists. Subsequently,
we reduced the number of items by using the Delphi consensus technique. Each Delphi round comprised a
questionnaire, an analysis, and a feedback report. The feedback report included staff team decisions made on the
basis of the analysis and their justification. A total of 33 international experts agreed to participate, of whom 21
completed all questionnaires. The initial item pool of 206 items was reduced to 9 items in three Delphi rounds.
The final criteria list (the Delphi list) was satisfactory to all participants. It is a starting point on the way to a
minimum reference standard for RCTs on many different research topics. This list is not intended to replace, but
 





















In recent years, the number of available randomized clinical
trials (RCTs) has grown exponentially. It is therefore al-
most impossible for clinicians to keep up with the increase
of scientific information from original research [1]. An im-
portant aim of reviewing the literature in health care is to
summarize the evidence on which clinicians need to base
their care and thus to provide the empirical basis for clini-
cal decision making. The overall conclusions of a review of-
ten appear to depend on the quality of both the individual
RCTs and the review process [2,3]. A clear description of
the strategies for identifying, selecting, and integrating the
information distinguishes a systematic review from the tra-
ditional narrative review [4,5]. Today, many systematic re-
views rely substantially on the assessment of the method-
ological quality of the individual trials [6–8].
“Quality” as a concept is not easy to define. Quality of
RCTs has recently been defined as “the likelihood of the
trial design to generate unbiased results” [9]. This definition
covers only the dimension of internal validity. Although
most articles proposing a criteria list to assess the method-
ological quality of RCTs do not explicitly define the con-
cept of quality [10], most lists measure at least three dimen-
sions that may encompass the concept of quality in its
broadest sense: internal validity, external validity, and sta-
tistical analysis [11–15]. Some authors distinguish an ethi-
cal component in the concept of quality as well [16,17].
The method to develop a quality criteria list is similar to
that of other measurement instruments, for example, “qual-
ity of life” scales [18]. Here, consensus methods are often
used to select and reduce the number of items. Consensus
studies are typically designed to combine the knowledge
and experience of experts with the limited amount of avail-
able evidence. From the existing consensus methods, we
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chose the Delphi technique [19,20] because of the number
of the participants we wanted to involve, the written proce-
dure, the anonymity of the comments, and the time avail-
able (approximately 2 years) to conduct the study.
The aim of this study is to achieve consensus among ex-
perts, implicitly based on both empirical evidence and per-
sonal opinion, on how the quality of RCTs can be measured
best, resulting in a quality criteria list. We have considered
two approaches to reach this goal: try to achieve consensus
on the definition of quality of RCTs and infer the necessary
items for a criteria list, or, conversely, try to achieve con-
sensus on items that, according to the participants, measure
quality of a trial and infer from those a definition, or a de-
scription of the concept, of quality. We considered the lat-
ter approach to have a higher chance of success.
To be able to measure the quality of the design and con-
duct of a trial, one has to rely on the quality of the report.
Our point of departure is the ideal situation, that is, that
the report presents an honest, accurate, and comprehensive
reflection of the conduct of the study. We regard the qual-
ity criteria list resulting from this study as a starting point
for a future minimum reference standard to be used in sys-
tematic reviews. As such, it is not intended to replace exist-
ing criteria lists but to facilitate comparison of reviews more
easily. This article presents the Delphi procedure and the
resulting criteria list in quality assessment of RCTs on






A staff team was formed to initiate this research and con-
sisted of all authors except L.M.B. All staff team members
are epidemiologists, one of whom is also a clinician and one
of whom has a statistical background. The others are medi-
cal doctors or health scientists. The staff team was responsi-
ble for the procedures of the selection of items and the par-
ticipants and was responsible for the construction of the
questionnaires, the analysis of the responses and the formu-
lation of the feedback.
 
Selection of the Items
 
For the development of the initial item pool, we collected
all items from existing quality criteria lists for RCTs. For





 [10], the doctoral thesis of Jadad [15], information
from the Methods group of the Cochrane Collaboration









































 Papers are included when a criteria list for
quality assessment of RCTs was presented. Papers were ex-
cluded when a modification of an existing list was used.
We made headings of various aspects of a design of an RCT,
(e.g., aim, study question, randomization, blinding), under
which all items were ordered. A total number of 17 head-
ings (or domains) were created. On the basis of this initial
item pool, we formulated the Delphi-1 questionnaire. To
generate a more complete item pool, the participants were




The participants had to be epidemiologists or statisticians
concerned with quality assessment in systematic reviews or
meta-analyses. We tried to achieve a wide range of different
points of view on quality assessment. First, we asked all first
(or co-) authors of a publication of an original quality crite-
ria list to participate, one (co-) author per original article.
Next, after an extensive brainstorm of the members of the
staff team, we generated a list of leading epidemiologists
and statisticians in the field of quality assessment. This re-
sulted in three groups of experts of roughly equal sizes: au-




During the whole Delphi procedure, we used structured
questions, for example: “Should this item be included into
the criteria list?” or “Do you agree with the rewording of
this time?” The answer options used were 5-point Likert-
scales (totally agree–totally disagree) or a “yes/no/don’t
know” answer format. We invited participants to give rea-
sons for their choices. After each Delphi round, a feedback
report was made to inform the participants about opinions
and arguments of the other participants. The staff team de-
cided, on the basis of the answers and arguments of the par-
ticipants, which items and questions would appear in the
next questionnaire. Staff team decisions were presented and
justified in the feedback report. The participants were given
the opportunity to react to, or when necessary oppose, the
arguments of other participants and the decisions made by
the staff team. Three or four Delphi rounds were considered
sufficient to reach consensus; consensus being defined as a




The analysis of the responses from the Delphi rounds was
both quantitative and qualitative. Quantitatively, we pre-
sented the mean scores on the 5-point Likert scales (strongly
disagree [0 points], moderately disagree [1 point], neutral [2
points], moderately agree [3 points], and strongly agree [4
points]) as a percentage of the maximum obtainable score.
For example: a mean score of 1.9 is 47.5% of the maximum
achievable score. For questions with a “yes/no/don’t know”
answer format we calculated a “yes minus no” score from
the number of participants who answered a “yes” on a spe-
 




cific question minus the number of participants who answered
“no,” The necessary cut-off points were determined based
on the data of each Delphi round. Qualitatively, we sum-




For every item, we asked the participants how strongly they
agreed to include it in the final criteria list (5-point Likert
scale). Participants were given the opportunity to suggest
alternative wording and to add extra items. Some items ba-
sically asked for the same information but were formulated
differently. Participants were able to choose the items in




The Delphi-2 questionnaire provided opinions on the
methods and results of procedural decisions made by the
staff team and questions about the formulation of the items
selected from Delphi-1 on which the participants agreed
most. We decided, on the basis of the mixed responses in
Delphi-1, to present all items not selected initially after
Delphi-1 again in Delphi-2 for a second chance. Partici-
pants were able to choose the items they considered to be
essential for the criteria list. Again, they were invited to




We reworded the initial items based on the arguments
given in Delphi-2, and we presented them in the Delphi-3
questionnaire. We asked whether the participants preferred
the rewording or the original phrasing. Furthermore, we
presented the items that received a second chance (based
on the answers in Delphi-2) to be included into the criteria
list. The participants were able to state which of these items
should be added into the final list of items. Subsequently,
we asked whether they agreed with the omission of domains




After Delphi-1, at the 3rd Cochrane Colloquium in Oslo in
1995 in a meeting with some of the participants, the issue
was raised of whether we should continue talking about the
“quality of RCTs” or whether we should limit ourselves to
identifying a set of “parameters which may be related to ef-
fect sizes,” which implies a restriction to internal validity.
Therefore, in Delphi-2 we asked the participants whether
they had problems with using the word “quality” related to
this criteria list. On the basis of their answers, we generated
two possible definitions about quality, and the participants
were asked in Delphi-3 which of the two different defini-






We were able to locate 15 of 17 identified authors (or co-
authors) of original criteria lists. One of them refused to
participate, and three did not respond. We located 13 of 19
epidemiologists, of whom two refused to respond and two
did not respond. Of the 15 statisticians we located, one re-
fused to respond and one did not respond. Potential partici-
pants declined mostly because they were too busy; only one
declined because he did not like the Delphi method for this
purpose. We started with 33 persons who agreed to partici-
pate, of whom 26 returned the first questionnaire and 21
the second and third questionnaires. One participant re-
turned the second and third questionnaire. Reasons mostly




A total of 24 papers were found presenting a criteria list
[9,10,13,14,16,21–40]. Several articles used the same crite-
ria list, namely the “Maastricht list” [33–39] or the list de-
veloped by Chalmers [13,40]. Once, a double publication of
the same criteria list was found [27,28]. We started with 17
articles [9,10,13,14,16,21–33] after excluding articles in
which a modification of the “Chalmers list” or the “Maas-
tricht list” was used. From these criteria lists, we generated
a large initial item pool of 206 items ordered under 17 do-
mains. Of the 33 Delphi-1 questionnaires, 26 were returned
and analyzed.
The initial item list generated intense disagreement: on








 52) five or more participants scored
“strongly agree” to include this item, whereas five or more
other participants scored “strongly disagree” to include that
item (Table 1). The disagreement was in part due to differ-
ent formulations of the items but also to the different prior-
ities of the statisticians and the epidemiologists regarding
the inclusion of statistical items. Epidemiologists stated re-
peatedly that items concerning the statistical analysis had
nothing to do with the quality of RCTs, whereas the statis-




sample size calculation to be of importance to quality. Ta-
ble 1 shows examples of items on which the participants
disagreed strongly.
We saw no obvious difference in scoring between the au-
thors and the epidemiologists, but we observed a difference
when we divided the participants in statisticians on the one




 authors on the other. The stat-
isticians scored 31 items greater than 70% of the maximum
obtainable score, of which five items concerned statistical














The aim of the staff team was a
short final criteria list. On the basis of the data, we chose a
rather high cut-off point of 70%, resulting in a preliminary








the procedure. The feedback report of the Delphi-1 pre-
sented all items with their scores in percentage and all com-
ments made by the participants (anonymously). We de-
cided to present all items of Delphi-1 again in Delphi-2 so
that participants were able to reconsider their first deci-





Of the 33 Delphi-2 questionnaires sent to all initial partici-
pants, 21 were returned and analyzed. Nonresponse was
mainly in the authors/epidemiologists group. The most re-
ported reason was lack of time, and one participant was on
maternity leave. Eight participants agreed with the cut-off
point of 70%, whereas nine participants answered “don’t









the seven initial items to be included, but all considered re-
phrasing of most items necessary. Most participants chose
some of the items from Delphi-1 that had a score below the














The data showed a large group of
“second-chance items” that were never chosen or were cho-
sen by only one or two participants; that is, most partici-
pants did not believe those items were essential. We de-
cided to give the items chosen at least four times a final
chance to be included. Table 2 presents the reworded pre-





All 21 Delphi-3 questionnaires sent to the participants of
Delphi-2 were returned and analyzed. The majority of the
participants accepted the rewording of the initial items.
One second-chance item was added to the final criteria list
because 19 participants regarded this item as essential. On
the other items, the opinion on whether or not to include
was divided with roughly equal “yes” and “no” responses.
We decided these items to be important but not essential
and, thus, did not include them in the final criteria list.
This final list is called the Delphi list (Table 3) and in-
cludes a description about the interpretation of the items as
well (available upon request from the first author).





According to the majority of the participants, restriction of


















26) showed strong disagreement
 
Items
Number of participants who 
answered “strongly agree”: this 
item must be included 
in the list
Number of participants that 
answered “strongly disagree”: 
this items must not be included in 
the list
 
The study design is:
a. Poor (e.g., no comparative groups)
9 10
b. Inadequate (e.g., comparative single blind or open)
c. Adequate (e.g., comparative, double blind)
Is the method described used to conceal the intervention 
assignment schedule from participants and clinicians 
until recruitment was complete and irrevocable? 10 7
Was the study described as randomized (this includes the use 
of words such as randomly, random and randomization)? 7 6




All items selected for the definitive criteria list
 
Items selected and reworded in Delphi-2
1. Treatment allocation
a) Was a method of randomization performed?
b) Was the treatment allocation blinded?
2. Are the groups similar at baseline regarding the most 
important prognostic indicators?
3. Eligibility criteria
a) Are the inclusion criteria operationalized?
b) Are exclusion criteria operationalized?
4. Was the outcome assessor blinded?
5. Was the therapist care/provider blinded?
6. Is the numerical information regarding the primary end point 
sufficient to enable statistical pooling?
7. Does the analysis include an intention-to-treat analysis?
Items receiving a final chance in Delphi-3 to be included also
1. Is the withdrawal/drop-out rate unlikely to cause bias?
2. Are therapeutic and control regimens/interventions 
operationalized?
3. Is the compliance rate (in each group) unlikely to cause bias?
4. Is controlled for cointerventions which could explain the 
results?
5. Was the patient blinded?
6. Is a sample size justification described?
 




of “quality,” and, consequently, a definition of quality
should also contain elements of external validity and the
statistical analysis. But during the process, we noticed in-
consistencies, even within participants within one Delphi
round. For example, a participant stated explicitly on one
page that quality was only concerned with internal validity.
But on the next page, the same participant suggested the
inclusion of three items into the final criteria list that
clearly concerned the external validity. Therefore, the staff
team generated two different definitions based on the an-
swers of Delphi-2. The first definition was: 
 
Quality is a set of
parameters in the design and conduct of a study related to effect
sizes.
 
 This definition had emerged from a workshop with
some of the participants at the 3rd Cochrane Colloquium
in Oslo. The second definition was generated from the re-
marks in the Delphi-2 questionnaire: 
 
Quality is a set of pa-
rameters in the design and conduct of a study that reflects the va-
lidity of the outcome, related to the external and internal validity










 17) of the participants in Delphi-3
were in favor of the second definition of quality, but most of
them did not like the phrasing. Only two participants pre-
ferred the first definition, and two participants answered
“don’t know.” The participants achieved consensus on
quality being more than internal validity alone, but the





After three Delphi rounds, the participants achieved con-
sensus on a generic core set of items for quality assessment
in RCTs. Because of the chosen Delphi consensus proce-
dure, we will call this list the Delphi List. In our effort to
develop a criteria list, we chose not to define the word
“quality” beforehand because a well-accepted definition
does not exist. We assumed that the participants (all ex-
perts in the field of quality assessment) would have their
own clear picture of what quality is. The advantage of a
consensus method such as the Delphi approach is that the
different ideas of the concept of quality integrate in the re-
sulting criteria list, thus determining the content validity.
During the process, most participants appeared to have dif-
ficulties with this approach, and we decided to try to formu-
late a definition of quality.
In a consensus procedure, the choice of the participants




Final Delphi List after three Delphi rounds
 
1. Treatment allocation
a) Was a method of randomization 
performed? Yes/No/Don’t know
b) Was the treatment allocation 
concealed? Yes/No/Don’t know
2. Were the groups similar at baseline 
regarding the most important prognostic 
indicators? Yes/No/Don’t know
3. Were the eligibility criteria specified? Yes/No/Don’t know
4. Was the outcome assessor blinded? Yes/No/Don’t know
5. Was the care providor blinded? Yes/No/Don’t know
6. Was the patient blinded? Yes/No/Don’t know
7. Were point estimates and measures of 
variability presented for the primary 
outcome measures? Yes/No/Don’t know
8. Did the analysis include an intention-to-




Items and domains per Delphi round
 
Domains
Number of items 
in Delphi-1 and -2
Number of items 
in Delphi-3
Number of items 
in final Delphi list
 
1. Study question 2 — —
2. Population 15 1 1






4. Treatment allocation 12 1 1
5. Study design 2 — —
6. Ethics 4 — —
7. Intervention 19 1 —
8. Outcome measures 21 — —
9. Follow-up/withdrawals 14 1 —
10. Blinding 28 3 3
11. Cointervention 5 1 —
12. Side-effects 5 — —
13. Compliance 6 1 —
14. Prognostic comparability 6 1 1
15. Analysis 41 2 2
16. Conclusion 10 — —








pants, our aim was to achieve a broad representation of all
different points of view on quality assessment using three
different groups of roughly equal sizes.
In a Delphi consensus procedure, the staff team has to
decide about the procedural steps [19,20]. Their decisions
can vary from fully autocrative to fully democratic. Because
of the expected fundamental differences, we assumed that a
too-directive role would be ineffective. Therefore, we de-
cided to allow all Delphi-1 items for a second chance. The
data of Delphi-2 showed much more agreement, and we
considered that a consensus could be achieved. After Del-
phi-3, the participants seemed satisfied with the resulting
criteria list, and we believed no new arguments were given,
so a fourth round would probably not add new or different
information.
Based on the comments and remarks of the participants
during the whole procedure, an Appendix has been con-
structed on the interpretation of the items. The reviewers
have to decide, depending on the topic of the review,
whether enough information is provided to score a “yes” on
certain items. As long as these decisions are stated explic-
itly in the review, it will be clear for the reader how the
items are scored and a comparison with reviews on other
topics using the same criteria list can be made.
Empirical research concerning assessment of the meth-
odological quality of RCTs is relatively new. Awaiting em-
pirical research, we think it is useful to prioritize items using
a group of experts. All different opinions in this field of re-
search should be respected at this stage. Starting this re-
search, we were well aware of the different views on quality
and quality assessment of RCTs. Despite this knowledge,
we were surprised by the many initial differences between
the participants. Notwithstanding these differences, the
participants achieved consensus on the final Delphi List.
New in the ongoing discussion about quality is that we
achieved broad consensus concerning the need for inclu-
sion of three dimensions of quality into any definition of
the “concept” of quality: “internal validity,” “external va-
lidity,” and “statistical considerations.” In the feedback of
Delphi-3, in which we presented the Delphi List to the par-
ticipants as a result of this research project, we asked partic-
ipants to react to the final result. No negative and four pos-
itive reactions or comments were received.
When a consensus concerning the content of a criteria
list is reached, the following issue of what to do with the re-
sults of quality assessment has to be addressed. A quality
criteria list can be used in different ways [33,38,40,41]. It
can provide a quality score as an estimate of the method-
ological quality. These quality scores can be used as a
“threshold score” for inclusion of the article in a review, as
a “weighting factor” in the statistical analysis [40,42,43], or
as the input sequence in a cumulative meta-analysis [43–
45]. Sometimes a visual plot of the effect size against a qual-
ity score is presented [40,42,43]. The next step will be to
achieve consensus (based on empirical evidence) about
how to incorporate quality into the final conclusions of a




The participants in this Delphi process achieved consensus
on a generic criteria list for quality assessment in RCTs: the
Delphi List. The adoption of this core set by the partici-
pants and other researchers may be the first step toward a
minimum reference standard of quality measures for all
RCTs. It is not our intention to replace existing criteria
lists, but we suggest it should be used alongside these lists.
The validity of this criteria list will have to be measured
and evaluated over time.
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